Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: A case report

Journal of Medical Case Reports

Volumn 1, Issue , 2007, Pages

  Todder, Doron ^a   Baune, Bernhard T ^b,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; COMORBIDITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EJACULATION DISORDER; FAMILY THERAPY; HUMAN; MALE; MORNING DOSAGE; NARCISSISM; OUTPATIENT CARE; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENT DISEASE; SUICIDAL IDEATION;

EID: 45349084075     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-1-166     Document Type: Article

References (25)

1. Teicher MH Glod C Cole JO Emergence of intense suicidal preoccupation during fluoxetine treatment Am J Psychiatry 1990. 147(2):207-210. 2301661
2. UK Medicines and Health Care Products Regulatory Agency release. DH Seroxat must not be used for treatment of children. 2003
3. Akiskal HS Benazzi F Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population? J Affect Disord 2006, 94(1-3):105-110. 10.1016/ j.jad.2006.04.002 16766043
4. Healy D Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors Psychother Psychosom 2003, 72(2):71-79. 10.1159/000068691 12601224
5. APA Diagnostic and Statistical Manual of Mental Disorders [4th ed] (DSM-IV) 1994.
6. Simon GE Savarino J Operskalski B Wang PS Suicide risk during antidepressant treatment Am J Psychiatry 2006, 163(1):41-47. 10.1176/ appi.ajp.163.1.41 16390887
7. Jick SS Dean AD Jick H Antidepressants and suicide Bmj 1995, 310(6974):215-218. 7677826
8. Fergusson D Doucette S Glass KC Shapiro S Healy D Hebert P Hutton B Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials Bmj 2005, 330(7488):396. 549110 15718539 10.1136/bmj.330.7488.396
9. Isacsson G Holmgren P Ahlner J Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: A controlled forensic database study of 14,857 suicides Acta Psychiatr Scand 2005, 111(4):286-290. 10.1111/j.1600-0447.2004.00504.x 15740464
10. Gibbons RD Hur K Bhaumik DK Mann JJ The relationship between antidepressant medication use and rate of suicide Arch Gen Psychiatry 2005, 62(2):165-172. 10.1001/archpsyc.62.2.165 15699293
11. Gibbons RD Brown CH Hur K Marcus SM Bhaumik DK Erkens JA Herings RM Mann JJ Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents Am J Psychiatry 2007, 164(9):1356-1363. 10.1176/appi.ajp.2007.07030454 17728420
12. Healy D Langmaak C Savage M Suicide in the course of the treatment of depression J Psychopharmacol 1999, 13(1):94-99. 10221363
13. Healy D The three faces of the antidepressants: A critical commentary on the clinical-economic context of diagnosis J Nerv Ment Dis 1999, 187(3):174-180. 10.1097/00005053-199903000-00007 10086474
14. Akiskal HS Benazzi F Psychopathologic correlates of suicidal ideation in major depressive outpatients: Is it all due to unrecognized (bipolar) depressive mixed states? Psychopathology 2005, 38(5):273-280. 10.1159/ 000088445 16179814
15. Rothschild AJ Locke CA Reexposure to fluoxetine after serious suicide attempts by three patients: The role of akathisia J Clin Psychiatry 1991, 52(12):491-493. 1752848
16. George DT Anderson P Nutt DJ Linnoila M Aggressive thoughts and behavior: Another symptom of panic disorder? Acta Psychiatr Scand 1989, 79(5):500-502. 10.1111/j.1600-0447.1989.tb10294.x 2750551
17. Celada P Puig M Amargos-Bosch M Adell A Artigas F The therapeutic role of 5-HT1A and 5-HT2A receptors in depression J Psychiatry Neurosci 2004, 29(4):252-265. 446220 15309042
18. Adell A Artigas F Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study Naunyn Schmiedebergs Arch Pharmacol 1991, 343(3):237-244. 10.1007/BF00251121 1714040
19. Bel N Artigas F Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study Eur J Pharmacol 1992, 229(1):101-103. 10.1016/0014-2999(92)90292-C 1282104
20. Invernizzi R Belli S Samanin R Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex Brain Res 1992, 584(1-2):322-324. 10.1016/0006-8993(92)90914-U 1515949
21. Blier P de Montigny C Current advances and trends in the treatment of depression Trends Pharmacol Sci 1994, 15(7):220-226. 10.1016/ 0165-6147(94)90315-8 7940983
22. Quinaux N Scuvee-Moreau J Dresse A Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones Naunyn Schmiedebergs Arch Pharmacol 1982, 319(1):66-70. 10.1007/BF00491480 7110371
23. Souery D Oswald P Linkowski P Mendlewicz J Molecular genetics in the analysis of suicide Ann Med 2003, 35(3):191-196. 10.1080/ 07853890310008242 12822741
24. Flouri E Psychological and sociological aspects of parenting and their relation to suicidal behavior Arch Suicide Res 2005, 9(4):373-383. 10.1080/13811110500182463 16179334
25. Compton MT Thompson NJ Kaslow NJ Social environment factors associated with suicide attempt among low-income African Americans: The protective role of family relationships and social support Soc Psychiatry Psychiatr Epidemiol 2005, 40(3):175-185. 10.1007/s00127-005-0865-6 15742221